Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Cambodian Drugmakers Have Few Options Despite Rising Illness

      Drug Development
      Despite the increased prevalence of both communicable and non-communicable diseases in the nation, the commercial potential for medication manufacturers in Cambodia will remain restricted,...

      BioMarin, CSL- Haemophilia Gene Treatments Win ICER Backing

      FDA Approvals
      Upcoming gene therapies may be the most economical option for people with haemophilia types A and B to address their illness, even with a...

      WHO Advocates For More Research For Long COVID Patients

      News
      The WHO has urged nations to invest promptly in research, recovery, and rehabilitation in order to treat the post-COVID-19 syndrome seriously. At least 17 million...

      $300mn To Be Funded By Novartis In European Biotherapeutics

      Drug Development
      The next-generation biotherapeutics will receive $300 million from Novartis, according to the company. To build a fully integrated, dedicated scientific environment to boost its...

      Monkeypox Antiviral Clinical Trial Launches In United States

      Clinical Trials
      In the United States, adults and kids with monkeypox infection are now being enrolled in a Phase 3 clinical trial assessing the antiviral tecovirimat,...

      Fresh Lumakras Lung Cancer Data From Amgen Fuel KRAS Dispute

      Clinical Trials
      Amgen is in the lead in a carefully watched race among KRAS inhibitors after winning a lung cancer randomised study. Now, the California drugmaker...

      EU Authorities Outline A New Clinical Research Timeline

      Clinical Trials
      The European Commission (EC), Heads of Medicine Agencies (HMA), and European Medicines Agency (EMA) have released the 2022–2026 workplan for the programme Accelerating Clinical...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.